Skip to main content
. Author manuscript; available in PMC: 2010 Mar 1.
Published in final edited form as: Pharmacogenet Genomics. 2009 Mar;19(3):206–216. doi: 10.1097/FPC.0b013e328323f680

Table 5.

Resistance factors of transfected CHO-K1 cells to chemotherapeutic agents.

Resistance factora
Drugs WT-MRP1/ABCC1 Cys43Ser (128G>C) Thr73lle (218C>T) Arg723Gln (2168G>A) Arg1058Gln (3173G>A)
Cisplatin 0.94±0.05 0.98±0.12 0.89±0.04 0.99±0.09 0.89±1.10
Paclitaxel 0.94±0.11 0.88±0.10 0.96±0.05 1.00±0.07 0.96±0.06
Daunorubicin 12.97±2.76 13.09±2.68 13.07±2.81 2.96±0.58 4.81±1.01
Doxorubicin 15.44±1.37 15.84±0.91 15.44±1.95 6.46±0.90 7.22±0.86
Etoposide 16.57±1.91 16.44±1.95 4.84±0.51 3.56±0.36 4.77±0.56
Methotrexate 3.78±1.07 3.70±1.01 3.60±1.39 3.75±1.08 1.67±0.53
Vinblastine 10.35±1.61 10.32±1.70 10.27±1.66 5.73±0.87 8.50±1.32
Vincristine 6.93±1.13 6.78±1.18 6.79±1.04 2.27±0.34 6.85±1.14
a

Resistance factors=IC50 of wild-type or mutant MRP1/ABCC1 transfected cells/IC50 of empty vector control transfected cells.